124 related articles for article (PubMed ID: 20004471)
1. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography.
Davies A; Hayes AK; Knight K; Watmough SJ; Pirmohamed M; Clark RE
Leuk Res; 2010 Jun; 34(6):702-7. PubMed ID: 20004471
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection.
Guetens G; Prenen H; De Boeck G; van Oosterom A; Schöffski P; Highley M; de Bruijn EA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):341-5. PubMed ID: 16962394
[TBL] [Abstract][Full Text] [Related]
3. Determination of imatinib plasma levels in patients with chronic myeloid leukemia by high performance liquid chromatography-ultraviolet detection and liquid chromatography-tandem mass spectrometry: methods' comparison.
Awidi A; Salem II; Najib N; Mefleh R; Tarawneh B
Leuk Res; 2010 Jun; 34(6):714-7. PubMed ID: 19744707
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
Miura M; Takahashi N; Sawada K
J Chromatogr Sci; 2011 May; 49(5):412-5. PubMed ID: 21549035
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.
Parise RA; Ramanathan RK; Hayes MJ; Egorin MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):39-44. PubMed ID: 12798163
[TBL] [Abstract][Full Text] [Related]
6. New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1721-6. PubMed ID: 19428316
[TBL] [Abstract][Full Text] [Related]
7. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
Tan KL; Ankathil R; Gan SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3583-91. PubMed ID: 22000961
[TBL] [Abstract][Full Text] [Related]
8. Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed-phase high-performance liquid chromatography.
Oostendorp RL; Beijnen JH; Schellens JH; Tellingen Ov
Biomed Chromatogr; 2007 Jul; 21(7):747-54. PubMed ID: 17385801
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples.
Velpandian T; Mathur R; Agarwal NK; Arora B; Kumar L; Gupta SK
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):431-4. PubMed ID: 15081939
[TBL] [Abstract][Full Text] [Related]
10. Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glivec capsules.
Ivanovic D; Medenica M; Jancic B; Malenovic A
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Feb; 800(1-2):253-8. PubMed ID: 14698262
[TBL] [Abstract][Full Text] [Related]
11. Validation of an HPLC method for determination of imatinib mesylate in rat serum and its application in a pharmacokinetic study.
Bende G; Kollipara S; Movva S; Moorthy G; Saha R
J Chromatogr Sci; 2010; 48(5):334-41. PubMed ID: 20515524
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
Kralj E; Trontelj J; Pajič T; Kristl A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
[TBL] [Abstract][Full Text] [Related]
13. Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.
Guetens G; Prenen H; De Boeck G; Highley M; de Wever I; van Oosterom AT; de Bruijn EA
J Sep Sci; 2006 Feb; 29(3):453-9. PubMed ID: 16544888
[TBL] [Abstract][Full Text] [Related]
14. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
Moreno JM; Wojnicz A; Steegman JL; Cano-Abad MF; Ruiz-Nuño A
Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
[TBL] [Abstract][Full Text] [Related]
15. Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
Zhang M; Moore GA; Fernyhough LJ; Barclay ML; Begg EJ
Anal Bioanal Chem; 2012 Oct; 404(6-7):2091-6. PubMed ID: 22865010
[TBL] [Abstract][Full Text] [Related]
16. Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection.
Widmer N; Béguin A; Rochat B; Buclin T; Kovacsovics T; Duchosal MA; Leyvraz S; Rosselet A; Biollaz J; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):285-92. PubMed ID: 15063337
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic assay for the determination of nilotinib in human plasma.
Yuki M; Yamakawa Y; Uchida T; Nambu T; Kawaguchi T; Hamada A; Saito H
Biol Pharm Bull; 2011; 34(7):1126-8. PubMed ID: 21720025
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations.
Schleyer E; Pursche S; Köhne CH; Schuler U; Renner U; Gschaidmeier H; Freiberg-Richter J; Leopold T; Jenke A; Bonin M; Bergemann T; le Coutre P; Gruner M; Bornhäuser M; Ottmann OG; Ehninger G
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):23-36. PubMed ID: 14659433
[TBL] [Abstract][Full Text] [Related]
19. Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Titier K; Picard S; Ducint D; Teilhet E; Moore N; Berthaud P; Mahon FX; Molimard M
Ther Drug Monit; 2005 Oct; 27(5):634-40. PubMed ID: 16175138
[TBL] [Abstract][Full Text] [Related]
20. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
